兔模型门静脉栓塞后肝实质离断增加肝体积但不增加功能
该研究在12只兔门静脉栓塞模型中随机比较肝实质离断与单纯栓塞,用CT体积测量和99mTc-mebrofenin肝胆闪烁显像评估肝体积与摄取功能。结果显示离断组非栓塞肝叶体积增长显著大于单纯栓塞组,但两组肝摄取功能无差异,提示联合肝脏离断和门静脉结扎的分期肝切除术(ALPPS)后的快速体积增长并不伴随功能同步增加。
要点
- 门静脉栓塞后加肝实质离断可加速肝体积增长但不增加肝摄取功能。
- ALPPS术后体积快速增大不等同于功能同步提升。
- 定量肝功能检测可能有助于更准确评估ALPPS的肝脏肥大反应。
核心结论
- 门静脉栓塞后行肝实质离断可增加肝体积但不增加肝摄取功能。
- ALPPS后观察到的快速体积增长并不伴随临床更相关的功能增加。
研究设计与样本
- 标准化兔模型研究,12只兔行头侧肝叶门静脉栓塞后随机分为左外侧肝叶实质离断组与单纯门静脉栓塞组。
- 用CT体积测量评估非栓塞肝叶体积,用99mTc-mebrofenin肝胆闪烁显像测定肝摄取功能,时间点为栓塞前及栓塞后3天和7天。
主要发现
- 门静脉栓塞后3天,离断组非栓塞肝叶体积增加为单纯栓塞组的2.7倍(56 ± 16% vs 21 ± 12%,P < .01)。
- 门静脉栓塞后7天,离断组体积增加为单纯栓塞组的1.7倍(113 ± 34% vs 68 ± 24%,P < .01)。
- 两组肝摄取功能在栓塞前、栓塞后3天和7天均无差异。
临床怎么用
- 在ALPPS中应重视肝功能定量评估,而非仅依赖体积增长判断肥大反应。
- 定量肝功能检测可能有助于改善ALPPS的临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Associating liver partition with portal vein ligation for staged hepatectomy induces more extensive liver hypertrophy than ligation alone; however, the mechanisms underlying the accelerated liver regrowth and the functional quality of the hypertrophic liver are presently elusive. This study, therefore, investigated the effect of parenchymal transection on liver volume and function after portal vein embolization in a standardized rabbit model. METHODS: Twelve rabbits were subjected to portal vein embolization of the cranial liver lobes and randomized between parenchymal transection of the left lateral liver lobe versus no transection (portal vein embolization only). Liver volume of the nonembolized liver lobe was assessed using computed tomography-volumetry, and liver uptake function was determined by 99mTc-mebrofenin hepatobiliary scintigraphy before and 3 and 7 days after portal vein embolization. RESULTS: The increase in nonembolized liver volume 3 days after portal vein embolization was 2.7-fold greater in the transected group compared with the portal vein embolization only group (56 ± 16% vs 21 ± 12%, respectively, P < .01) and 1.7-fold greater 7 days after portal vein embolization (113 ± 34% vs 68 ± 24%, P < .01). Liver uptake function did not differ between groups before portal vein embolization (8.4 ± 3.7%/min in the transection group vs 8.9 ± 1.6%/min) on day 3 (33.2 ± 4.7% after transection vs 30.3 ± 4.6%/min, respectively) and day 7 after portal vein embolization (42.6 ± 8.4% vs 39.1 ± 5.3%/min, respectively). CONCLUSION: Parenchymal transection after portal vein embolization increases liver growth in terms of volume but not function. These results indicate that the rapid volume increase observed after associating liver partition with portal vein ligation for staged hepatectomy does not coincide with the clinically more relevant functional increase. Quantitative liver function tests might be essential in associating liver partition with portal vein ligation for staged hepatectomy to better assess the hypertrophy response and improve clinical decision-making.
引用
- Olthof PB, Schadde E, van Lienden KP, et al. Hepatic parenchymal transection increases liver volume but not function after portal vein embolization in rabbits. Surgery. 2017. PMID: 28173999. doi:10.1016/j.surg.2016.12.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。